Bone Metastasis on the Survival of Gefitinib Effective Patients

Bone Metastasis on the Survival of Gefitinib Effective Patients With Non-small Cell Lung Cancer

NCT03157310•Qilu Hospital of Shandong University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Overal Survival, Non-small Cell Lung Cancer

Interventions

Gefitinib

Key Dates

Start Date

May 1, 2009

Primary Completion Date

May 1, 2013

Completion Date

July 12, 2015

Last Updated

May 17, 2017

Sponsors

Lead Sponsor

Qilu Hospital of Shandong University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 17, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions